Human immunodeficiency virus type 1 gp120 induces anergy in human peripheral blood lymphocytes by inducing interleukin-10 production.

Por Schols, D, De Clercq, E
Publicado em 1996

RANTES and MCP-3 inhibit the replication of T-cell-tropic human immunodeficiency virus type 1 strains (SF-2, MN, and HE).

Por Schols, D, Proost, P, Van Damme, J, De Clercq, E
Publicado em 1997

Specific interaction of aurintricarboxylic acid with the human immunodeficiency virus/CD4 cell receptor.

Por Schols, D, Baba, M, Pauwels, R, Desmyter, J, De Clercq, E
Publicado em 1989

Alpha-(1-3)- and alpha-(1-6)-D-mannose-specific plant lectins are markedly inhibitory to human immunodeficiency virus and cytomegalovirus infections in vitro.

Por Balzarini, J, Schols, D, Neyts, J, Van Damme, E, Peumans, W, De Clercq, E
Publicado em 1991

Differential antiherpesvirus and antiretrovirus effects of the (S) and (R) enantiomers of acyclic nucleoside phosphonates: potent and selective in vitro and in vivo antiretrovirus...

Por Balzarini, J, Holy, A, Jindrich, J, Naesens, L, Snoeck, R, Schols, D, De Clercq, E
Publicado em 1993

Novel sulfated polymers as highly potent and selective inhibitors of human immunodeficiency virus replication and giant cell formation.

Por Baba, M, Schols, D, De Clercq, E, Pauwels, R, Nagy, M, Györgyi-Edelényi, J, Löw, M, Görög, S
Publicado em 1990

Phosphonylmethoxyethyl purine derivatives, a new class of anti-human immunodeficiency virus agents.

Por Pauwels, R, Balzarini, J, Schols, D, Baba, M, Desmyter, J, Rosenberg, I, Holy, A, De Clercq, E
Publicado em 1988

Cell type-specific anti-human immunodeficiency virus type 1 activity of the transactivation inhibitor Ro5-3335.

Por Witvrouw, M, Pauwels, R, Vandamme, A M, Schols, D, Reymen, D, Yamamoto, N, Desmyter, J, De Clercq, E
Publicado em 1992

Potent and selective inhibition of human immunodeficiency virus (HIV)-1 and HIV-2 replication by a class of bicyclams interacting with a viral uncoating event.

Por De Clercq, E, Yamamoto, N, Pauwels, R, Baba, M, Schols, D, Nakashima, H, Balzarini, J, Debyser, Z, Murrer, B A, Schwartz, D
Publicado em 1992

2',5'-Bis-O-(tert-butyldimethylsilyl)-3'-spiro-5''-(4''-amino-1'',2''- oxathiole-2'',2'-dioxide)pyrimidine (TSAO) nucleoside analogues: highlyselective inhibitors of human immunode...

Por Balzarini, J, Pérez-Pérez, M J, San-Félix, A, Schols, D, Perno, C F, Vandamme, A M, Camarasa, M J, De Clercq, E
Publicado em 1992

Potent and highly selective human immunodeficiency virus type 1 (HIV-1) inhibition by a series of alpha-anilinophenylacetamide derivatives targeted at HIV-1 reverse transcriptase.

Por Pauwels, R, Andries, K, Debyser, Z, Van Daele, P, Schols, D, Stoffels, P, De Vreese, K, Woestenborghs, R, Vandamme, A M, Janssen, C G
Publicado em 1993

New tetrahydroimidazo[4,5,1-jk][1,4]-benzodiazepin-2(1H)-one and -thione derivatives are potent inhibitors of human immunodeficiency virus type 1 replication and are synergistic wi...

Por Pauwels, R, Andries, K, Debyser, Z, Kukla, M J, Schols, D, Breslin, H J, Woestenborghs, R, Desmyter, J, Janssen, M A, De Clercq, E
Publicado em 1994

SRR-SB3, a disulfide-containing macrolide that inhibits a late stage of the replicative cycle of human immunodeficiency virus.

Por Witvrouw, M, Balzarini, J, Pannecouque, C, Jhaumeer-Laulloo, S, Esté, J A, Schols, D, Cherepanov, P, Schmit, J C, Debyser, Z, Vandamme, A M, Desmyter, J, Ramadas, S R, de Clercq, E
Publicado em 1997